Ken Griffin Warby Parker Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$11.46 - $15.04 $1,146 - $1,504	100 Added 0.73%	13,800 $187,000
Q4 2023 Feb 14, 2024	BUY	$10.06 - $14.8 $21,126 - $31,080	2,100 Added 18.1%	13,700 $193,000
Q3 2023 Nov 14, 2023	SELL	$11.59 - $14.94 $277,001 - $357,066	-23,900 Reduced 67.32%	11,600 $152,000
Q2 2023 Aug 14, 2023	SELL	$10.23 - $12.21 $9,207 - $10,989	-900 Reduced 2.47%	35,500 $414,000
Q1 2023 May 15, 2023	SELL	$9.69 - $17.54 $534,888 - $968,208	-55,200 Reduced 60.26%	36,400 $385,000

Q4 2022 Feb 14, 2023	SELL	$12.99 - $18.8 $5.5 Million - $7.96 Million	-423,600 Reduced 82.22%	91,600 $1.24 Million
Q3 2022 Nov 14, 2022	SELL	$11.18 - $17.92 $2.18 Million - $3.49 Million	-194,600 Reduced 27.42%	515,200 $6.87 Million

185

82M

467K

1.34M

Ticker WRBY
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 95,777,000
Market Cap $1.54B
Description
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its re...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.